USDA: hemp part of Europe’s environmental agenda; PA marijuana pardon deadline; States reap more taxes from cannabis than alcohol/tobacco Subscribe to...
The first thing anyone should know about psychedelic stocks is that it is a long game. If you are expecting a quick turn in profit for...
The article Atai Life Sciences Launches Phase 1 MDMA Trial was originally published on Microdose. “We continue to execute on our pipeline – having...
In 2021, one of the leading stories for psychedelic stock investors was the introduction of ETFs focused on the burgeoning sector. Here at Psychedelic...
Traditional psychedelics have shown great potential for treating issues like depression, anxiety, PTSD, and addiction. Psilocybin and MDMA will likely...
Psychologist Ralph Hood’s study of serpent handling and mysticism helped legitimize the study of psychedelics. So why doesn't he want them approved for...
The cannabis sector consists of 5 distinctly different categories and they each performed quite differently in August and since the end of June and YTD,...
NEW YORK and BERLIN, Sept. 07, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company...
The article Cathie Wood’s ARK Invest Releases Psychedelic Research Report was originally published on Microdose. We’ve been reporting on controversial...
Amidst the ongoing biotech market slowdown, companies are trying various ways to stay afloat. Some are going public, and some are taking on debt. The newest...